WHO世界卫生组织：2025年临床和临床前开发中的抗真菌药物：概述和分析报告（英文版）

This report presents the first World Health Organization (WHO) analysis of antifungal agents in clinical and preclinical development. It covers systemic antifungal drugs in development worldwide, including label extension and repurposed products, and critically evaluates how well the current pipeline addresses infections caused by WHO fungal priority pathogens. The scope of the report is to provide an overview